Anest. intenziv. Med. 2016;27(5):288-290

KOMENTÁŘ I. Aprotinin - nekonečný příběhAnaesthesiology - Special Article

R. Hájek
Kardiochirurgická klinika, Fakultní nemocnice Olomouc a Lékařská fakulta Univerzity Palackého v Olomouci

Received: July 7, 2016; Accepted: July 24, 2016; Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hájek R. KOMENTÁŘ I. Aprotinin - nekonečný příběh. Anest. intenziv. Med. 2016;27(5):288-290.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ferrraris, V. A., Brown, J. R., Despotis, G. J. et al. Update to The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann. Thorac. Surg. 2001, 91, p. 944-982. Go to original source...
    2. Karkouti, K., Beattie, W. S., Dattilo, K. M. et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion risk cardiac srurgery. Transfusion, 2006, 46, p. 327-338. Go to original source... Go to PubMed...
    3. Mangano, D. T.,Tudor, I.C., Dietzel C. The risk association with aprotinin in cardiac surgery. N. Engl. J. Med., 2006, 354, p. 353-365. Go to original source... Go to PubMed...
    4. Fergusson, D. A.,Hébert, P. C., Mazer, D. et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N. Engl. J. Med., 2008, 358, p. 2319-2331. Go to original source... Go to PubMed...
    5. Mc Mullan, V., Alston, R. P. Aprotinin and cardiac surgery: a sorry tale of evidence misused. BJA, 2013, 110, 5, p. 675-678. Go to original source... Go to PubMed...
    6. Hébert, P. C., Fergusson, D. A., Hutton, B. et al. Regulatory decisions pretaining to aprotinin may be putting patiens at risk. CMAJ, 2014, 186, p. 1379-1386. Go to original source... Go to PubMed...
    7. Royston, D. The current place of aprotinin in the management of bleeding. Aneasthesia, 2015, 70 (Suppl 1), p. 46-49. Go to original source... Go to PubMed...
    8. Ortmann, E., Besse, M. W., Klein, A. Antifibrinolytic agents in current anaesthetic practice. BJA, 2013, 111, 4, p. 549-563. Go to original source... Go to PubMed...
    9. Murkin, J. M., Falter, F, Granton, J. et al. High-dose tranexamic acid is associated with nonischemical clinical seizures in cardiac surgical patiens. Anesth. Analg., 2010, 110, p. 350-353. Go to original source... Go to PubMed...
    10. Karkouti, K., Wijeysubdera, D. N., Yau, T. M. et al. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth. Analg., 2010, 110, p. 21-29. Go to original source... Go to PubMed...
    11. Sander, M., Spies, C. D., Martiny, V. et al. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures - a retrospective analysis. Critical. Care, 2010, 39, p. 1808-1817. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.